Page 4«..3456..1020..»

J&J drops stem cell partner Capricor – BioPharma Dive

By admin

Dive Brief: While the loss of the deal has made a hole on the company's value, Capricor is looking on the bright side. "Over the last few years, and during the term of the Janssen option period, we believe that significant value for our CAP-1002 asset has been created through the demonstration of clinical proof-of-concept to treat Duchenne muscular dystrophy (DMD) and also from the progress that has been made towards the development of a commercial-scale manufacturing process for the cells," said Linda Marbn, Capricor's president and CEO

To Read More: J&J drops stem cell partner Capricor – BioPharma Dive
categoriaCardiac Stem Cells commentoComments Off on J&J drops stem cell partner Capricor – BioPharma Dive | dataJuly 11th, 2017
Read All

Dragon splashes down in Pacific with time-critical experiments – SpaceFlight Insider

By daniellenierenberg

Derek Richardson July 3rd, 2017 The CRS-11 Dragon capsule re-enters Earths atmosphere. Photo Credit: Jack Fischer / NASA SpaceXs CRS-11 Dragon capsule splashed down at 8:12 a.m

To Read More: Dragon splashes down in Pacific with time-critical experiments – SpaceFlight Insider
categoriaCardiac Stem Cells commentoComments Off on Dragon splashes down in Pacific with time-critical experiments – SpaceFlight Insider | dataJuly 8th, 2017
Read All

Dragon Splashes Down to Complete Resupply Mission – Space Daily

By daniellenierenberg

SpaceX's Dragon cargo craft splashed down in the Pacific Ocean at 8:12 a.m. EDT, west of Baja California and the recovery process is underway, marking the end of the company's eleventh contracted cargo resupply mission to the International Space Station for NASA. Expedition 52 astronauts Jack Fischer and Peggy Whitson of NASA released the SpaceX Dragon cargo spacecraft from the International Space Station's robotic arm right on schedule, at 2:41 a.m.

To Read More: Dragon Splashes Down to Complete Resupply Mission – Space Daily
categoriaCardiac Stem Cells commentoComments Off on Dragon Splashes Down to Complete Resupply Mission – Space Daily | dataJuly 7th, 2017
Read All

NantWorks acquires majority stake in Integrity Healthcare, will take over 6 Los Angeles hospitals – Healthcare Finance News

By JoanneRUSSELL25

Photo of Patrick Soon-Shiong courtesy NHS Confederation Billionaire physician Patrick Soon-Shiong's company NantWorks has acquired a majority stake in Integrity Healthcare, the company that manages nonprofit Verity Health System.

To Read More: NantWorks acquires majority stake in Integrity Healthcare, will take over 6 Los Angeles hospitals – Healthcare Finance News
categoriaCardiac Stem Cells commentoComments Off on NantWorks acquires majority stake in Integrity Healthcare, will take over 6 Los Angeles hospitals – Healthcare Finance News | dataJuly 6th, 2017
Read All

See SpaceX Dragon capsule reenter Earth’s atmosphere in this amazing photo – LA Daily News

By Sykes24Tracey

NASA says astronaut Jack Fischer shot this photo of the SpaceX Dragon capsule reentering Earths atmosphere before splashing down in the Pacific Ocean west of Baja California on at 5:12 a.m. Pacific time Monday July 3, 2017

To Read More: See SpaceX Dragon capsule reenter Earth’s atmosphere in this amazing photo – LA Daily News
categoriaCardiac Stem Cells commentoComments Off on See SpaceX Dragon capsule reenter Earth’s atmosphere in this amazing photo – LA Daily News | dataJuly 4th, 2017
Read All

VistaGen Therapeutics Reports Fiscal 2017 Financial Results and Provides Corporate Update – Markets Insider

By raymumme

SOUTH SAN FRANCISCO, CA--(Marketwired - June 29, 2017) - VistaGen Therapeutics Inc.(NASDAQ: VTGN), a clinical-stage biopharmaceutical company focused on developing new generation medicines for depression and other central nervous system (CNS) disorders, today reported its financial results for its fiscal year ended March 31, 2017. The Company also provided an update on its corporate progress, clinical status and anticipated milestones for AV-101, its orally available CNS prodrug candidate in Phase 2 development, initially as a new generation treatment for major depressive disorder (MDD). "With a team of industry experts and a focused strategy in place, we have established a strong foundation and embarked on paths to achieve several key catalysts within the next 18 months

To Read More: VistaGen Therapeutics Reports Fiscal 2017 Financial Results and Provides Corporate Update – Markets Insider
categoriaCardiac Stem Cells commentoComments Off on VistaGen Therapeutics Reports Fiscal 2017 Financial Results and Provides Corporate Update – Markets Insider | dataJuly 1st, 2017
Read All

VistaGen Therapeutics Reports Fiscal 2017 Financial Results and Provides Corporate Update – Benzinga

By JoanneRUSSELL25

SOUTH SAN FRANCISCO, CA--(Marketwired - June 29, 2017) - VistaGen Therapeutics Inc.

To Read More: VistaGen Therapeutics Reports Fiscal 2017 Financial Results and Provides Corporate Update – Benzinga
categoriaCardiac Stem Cells commentoComments Off on VistaGen Therapeutics Reports Fiscal 2017 Financial Results and Provides Corporate Update – Benzinga | dataJune 30th, 2017
Read All

Siberian scientists say stem cells can treat varicose veins – Russia Beyond the Headlines

By JoanneRUSSELL25

Scientists at the Institute of Chemical Biology and Fundamental Medicine (ICBFM) based in Siberia have discovered that stem cells can restore blood flow in veins with clots. Facebook Pinterest WhatsApp "Quite a lot of pathologies regarding veins still remain unstudied." Source: Getty Images To help treat varicose veins, scientists need to accelerate the growth of blood vessels, which would be a crucial development for cardiac medicine

To Read More: Siberian scientists say stem cells can treat varicose veins – Russia Beyond the Headlines
categoriaCardiac Stem Cells commentoComments Off on Siberian scientists say stem cells can treat varicose veins – Russia Beyond the Headlines | dataJune 30th, 2017
Read All

Mayo-Connected Regenerative Medicine Startup Inks Downtown Rochester Lease – Twin Cities Business Magazine

By NEVAGiles23

A regenerative medicine startup led by a Mayo Clinic cardiologist is setting up shop in a downtown Rochesters Minnesota BioBusiness Center, according to newly filed city documents.

To Read More: Mayo-Connected Regenerative Medicine Startup Inks Downtown Rochester Lease – Twin Cities Business Magazine
categoriaCardiac Stem Cells commentoComments Off on Mayo-Connected Regenerative Medicine Startup Inks Downtown Rochester Lease – Twin Cities Business Magazine | dataJune 29th, 2017
Read All

Aging and Heart Research Lead Station Science Today – Space Fellowship

By NEVAGiles23

Expedition 52 explored the aging process in space today and measured the lighting conditions on the International Space Station. The crew is also getting spacesuits ready for an upcoming Russian spacewalk

To Read More: Aging and Heart Research Lead Station Science Today – Space Fellowship
categoriaCardiac Stem Cells commentoComments Off on Aging and Heart Research Lead Station Science Today – Space Fellowship | dataJune 28th, 2017
Read All

VistaGen Announces Peer-Reviewed Publication in the Scandinavian Journal of Pain Highlighting Orally-Available AV … – Markets Insider

By LizaAVILA

SOUTH SAN FRANCISCO, CA--(Marketwired - June 22, 2017) - VistaGen Therapeutics Inc.(NASDAQ: VTGN), a clinical-stage biopharmaceutical company focused on developing new generation medicines for depression and other central nervous system (CNS) disorders, announced today a peer-reviewed publication in the Scandinavian Journal of Pain of two Phase 1 clinical studies of the effects of AV-101 (4-Cl-KYN), the Company's CNS prodrug candidate, as a potential non-opioid treatment for neuropathic pain. Safety data from both the single and multi-dose Phase 1 studies indicated that oral AV-101 was extremely safe and well tolerated, with no meaningful difference in adverse events (AEs) at any dose between AV-101 and placebo.

To Read More: VistaGen Announces Peer-Reviewed Publication in the Scandinavian Journal of Pain Highlighting Orally-Available AV … – Markets Insider
categoriaCardiac Stem Cells commentoComments Off on VistaGen Announces Peer-Reviewed Publication in the Scandinavian Journal of Pain Highlighting Orally-Available AV … – Markets Insider | dataJune 23rd, 2017
Read All

StemoniX Wins Red Herring Top 100 Award – PR Newswire (press release)

By NEVAGiles23

"Being named a Red Herring Top 100 winner is an incredible honor," said StemoniX CEO Ping Yeh. "We truly believe in the importance of what we're doing and in making medicine more effective and safer for everyone

To Read More: StemoniX Wins Red Herring Top 100 Award – PR Newswire (press release)
categoriaCardiac Stem Cells commentoComments Off on StemoniX Wins Red Herring Top 100 Award – PR Newswire (press release) | dataJune 22nd, 2017
Read All

Testing For Cardiotoxicity In 3D – Asian Scientist Magazine

By Sykes24Tracey

Researchers from Singapore have developed a 3D tissue model than can be used to test drugs for their effects on the heart in a more realistic manner. Asian Scientist Newsroom | June 22, 2017 | In the Lab AsianScientist (Jun.

To Read More: Testing For Cardiotoxicity In 3D – Asian Scientist Magazine
categoriaCardiac Stem Cells commentoComments Off on Testing For Cardiotoxicity In 3D – Asian Scientist Magazine | dataJune 22nd, 2017
Read All

Stem cell therapy relying on patient’s own unhealthy heart may be dangerous – Genetic Literacy Project

By raymumme

A new study at Tel Aviv University shows that stem cell therapy, one of the few treatments available to patients with severe and end-stage heart failure, can actually harm them unless it is done differently. We concluded that stem cells used in cardiac therapy should be drawn from healthy donors or be better genetically engineered for the patient, said lead researcher Jonathan Leor of the universitys Sackler Faculty of Medicine and Sheba Medical Center. Doctors use tissue or adult stem cells to replace damaged tissue, which encourages regeneration of blood vessel cells and new heart muscle tissue

To Read More: Stem cell therapy relying on patient’s own unhealthy heart may be dangerous – Genetic Literacy Project
categoriaCardiac Stem Cells commentoComments Off on Stem cell therapy relying on patient’s own unhealthy heart may be dangerous – Genetic Literacy Project | dataJune 21st, 2017
Read All

Study says some stem cells dangerous for heart patients | The Times … – The Times of Israel

By JoanneRUSSELL25

A new study at Tel Aviv University shows that stem cell therapy, one of the few treatments available to patients with severe and end-stage heart failure, can actually harm them unless it is done differently. We concluded that stem cells used in cardiac therapy should be drawn from healthy donors or be better genetically engineered for the patient, said lead researcher Jonathan Leor of the universitys Sackler Faculty of Medicine and Sheba Medical Center. Doctors use tissue or adult stem cells to replace damaged tissue, which encourages regeneration of blood vessel cells and new heart muscle tissue

To Read More: Study says some stem cells dangerous for heart patients | The Times … – The Times of Israel
categoriaCardiac Stem Cells commentoComments Off on Study says some stem cells dangerous for heart patients | The Times … – The Times of Israel | dataJune 21st, 2017
Read All

Stem Cell Clinics List | Stem Cells Freak

By NEVAGiles23

Here we have compiled a list of several clinics offering stem cell treatments. Please note that the "conditions treated" refers to the conditions that THEY claim to treat. Most, if not all, stem cell treatments (except hematopoietic stem cell transplantation) aren't FDA approved, meaning that they haven't been clincally tested for safety or efficacy.

To Read More: Stem Cell Clinics List | Stem Cells Freak
categoriaCardiac Stem Cells commentoComments Off on Stem Cell Clinics List | Stem Cells Freak | dataJune 21st, 2017
Read All

Israeli Scientists: Stem Cell Therapy Not Good for All Heart … – The Jewish Press – JewishPress.com

By JoanneRUSSELL25

Photo Credit: Nati Shohat / Flash 90 Patients with severe and end-stage heart failure have few treatment options available to them apart from transplants and miraculous stem cell therapy. But a new Tel Aviv University study has found that stem cell therapy may in fact harm patients with heart disease

To Read More: Israeli Scientists: Stem Cell Therapy Not Good for All Heart … – The Jewish Press – JewishPress.com
categoriaCardiac Stem Cells commentoComments Off on Israeli Scientists: Stem Cell Therapy Not Good for All Heart … – The Jewish Press – JewishPress.com | dataJune 19th, 2017
Read All

‘Yoga, meditation counters gene expression changes that cause stress’ – Daily Times

By NEVAGiles23

In a new study, researchers have uncovered a molecular explanation for the stress-relieving effects of such practices. Study leader Ivana Buric, of the Centre for Psychology at Coventry University in the United Kingdom, and colleagues found that mind-body interventions (MBIs) "reverse" changes in DNA that cause stress

To Read More: ‘Yoga, meditation counters gene expression changes that cause stress’ – Daily Times
categoriaCardiac Stem Cells commentoComments Off on ‘Yoga, meditation counters gene expression changes that cause stress’ – Daily Times | dataJune 19th, 2017
Read All

How 3D Printing Can Help Mend a Broken Heart – Newsweek

By raymumme

Each year, more than 700,000 people suffer myocardial infarction, aka a heart attack. Thanks to medical advances, there are myriad ways for a doctor to get the blood properly pumping and save a persons life. A cardiologist might give a patient medication to clear or loosen blockages.

To Read More: How 3D Printing Can Help Mend a Broken Heart – Newsweek
categoriaCardiac Stem Cells commentoComments Off on How 3D Printing Can Help Mend a Broken Heart – Newsweek | dataJune 18th, 2017
Read All

Hair dyes, relaxers tied to raised breast cancer risk – The Nation

By NEVAGiles23

islamabad - New research finds evidence of a link between use of certain hair products, such as dyes and relaxers, and raised risk of breast cancer in women. In their study report, the researchers explain that there is conflicting evidence on whether use of hair products, some of which contain cancer-causing chemicals, or carcinogens, can raise the risk of breast cancer in women.

To Read More: Hair dyes, relaxers tied to raised breast cancer risk – The Nation
categoriaCardiac Stem Cells commentoComments Off on Hair dyes, relaxers tied to raised breast cancer risk – The Nation | dataJune 18th, 2017
Read All